Avlon Pharma to develop medicines in Saudi Arabia

Avalon Pharma announced the signing of a memorandum of understanding with the Chinese company Orisco Pharma to collaborate on the development and manufacturing of complex medicines, including technology transfer and localizing production in Saudi Arabia. The partnership will commence with an initial project to produce the drug "Inclisiran," aiming to build a broader platform of RNA-based pharmaceutical products. This effort supports the company's capabilities in complex medicines and aligns with the localization of manufacturing as part of Saudi Vision 2030. The memorandum lasts for six months and involves negotiations over commercial and financial terms, with no costs specified at this stage. It also enhances Saudi Arabia's position as a hub for advanced pharmaceutical manufacturing.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل